A 27-year-old female presents to the outpatient clinic reporting an absence of menstruation for the past seven months. She previously experienced predictable cycles every 29 days. She denies hot flashes, nipple discharge, vision changes, or recent alterations in body weight. Physical examination shows a normal female escutcheon, no signs of hyperandrogenism, and an unremarkable bimanual pelvic examination. Arrange the following diagnostic steps in the most appropriate sequential order for evaluating this patient's condition, starting with the mandatory initial test.
- 1Perform a qualitative or quantitative human chorionic gonadotropin assay
- 2Evaluate basal serum levels of thyrotropin, prolactin, and follicle-stimulating hormone
- 3Perform a progestin withdrawal challenge using oral medroxyprogesterone acetate
- 4Administer a sequential combination of estrogen and progestin to assess outflow tract patency
Cevap
The correct sequence is: 1) Human chorionic gonadotropin assay, 2) Thyrotropin, prolactin, and follicle-stimulating hormone evaluation, 3) Progestin withdrawal challenge, 4) Sequential estrogen and progestin administration.
The evaluation of secondary amenorrhea follows a logical, step-wise algorithm to isolate the underlying etiology. Because pregnancy is the most common cause of secondary amenorrhea, a human chorionic gonadotropin (hCG) assay is the mandatory first step. Once pregnancy is excluded, the clinician should measure serum thyrotropin (TSH), prolactin, and follicle-stimulating hormone (FSH) to identify hypothyroidism, hyperprolactinemia, and primary ovarian insufficiency or functional hypothalamic amenorrhea, respectively. If these initial screening laboratories are normal, a progestin challenge test (e.g., a short course of medroxyprogesterone acetate) is administered to assess the patient's endogenous estrogen status and the patency of the genital outflow tract. A patient with adequate estrogen will experience withdrawal bleeding. If no bleeding occurs, an estrogen-progestin challenge is performed to prime the endometrium. Bleeding after this combination indicates a hypoestrogenic state, whereas a continued absence of bleeding points to an anatomical outflow tract obstruction (e.g., Asherman syndrome).
Adım Adım Çözüm
Anahtar Kavram
The step-wise diagnostic evaluation of secondary amenorrhea begins with excluding pregnancy, followed by initial endocrine screening (TSH, prolactin, FSH), and then sequential hormonal challenges to evaluate the hypothalamic-pituitary-ovarian axis and uterine outflow tract.
Tahmini Süre:1m 30s